Sentences with phrase «of dividends over time»

Prudent investors should also be paying attention to dividend payout ratios (DPRs), which describe the degree to which companies can sustain payouts at the current level of dividends over time.

These small trades can build into a much bigger snowball of dividends over time.

These updates are mainly designed to show the increase or decrease in the value of the underlying equities I'm invested in, but the main purpose of investing in dividend growth stocks is for the rising stream of dividends over time.

For clients who desire both current income and opportunity for growth, our core portfolio focuses on the strongest companies which are committed to increasing shareholder wealth through the growth of dividends over time.

Informed with this knowledge, we developed the forward - looking Valuentum Dividend Cushion ™, which is a ratio that gauges the safety of a dividend over time.

Not exact matches

Over the same period of time it has paid out $ 40 million in dividends, and has spent $ 31 million repurchasing its own shares, including $ 16.5 million in the currently ongoing Normal Course Issuer Bid announced June 17, 2011; and,

Your initial outlay of $ 1,000 in 2008 would be worth more than $ 19,300 Thursday, according to CNBC calculations, or over 19 times as much, including price appreciation and dividend gains reinvested.

According to CNBC calculations, a $ 1,000 investment would be worth more than $ 11,200 as of Tuesday, or over 11 times as much, including price appreciation and dividend gains reinvested.

The group chairman, Jose Vinals, said in the same statement that the board «understands the importance of the ordinary dividend to shareholders and intends to increase the full year dividend per share over time.»

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

By increasing your time frame, mirroring indexes and taking advantage of dividends, you will likely build wealth over time.

Dollar General is now worth over $ 22 billion, and while, as previously mentioned, it had no dividend in 2010, it has recently started paying a dividend with an introductory yield of 1.2 % that is almost certain to grow in time — and it is a winner from a strong dollar.

But unless you got one heck of a deal, the delta in rent over dividends will have a very tough time making up for the 6 % per year difference in appreciation.

On top of this, the aggregate cash dividends received had paid back the initial outlay many, many, times over.

Best of all for shareholders, that dividend payment is easily covered by the company's operating cash flow, which gives investors reason to believe those dividends can continue to grow over time.

I absolutely do not believe that mutual funds are a better investment than individual stocks (companies that pay rising dividends over time) over the long run, so I invest the rest of my savings in a taxable account (as well as maxing out my Roth IRA every year, of which individual stocks are purchased).

If you've ever had occasion to look into the academic research comparing different types of returns from stocks that have different characteristics, as a class, dividend stocks tend to do better than the average stock over long periods of time.

These are defined as stocks that historically paid a persistently higher - than - average dividend (as a percentage of their share price) over time.

The point I'm trying to make... I will continue to make monthly buys at market highs and market lows as over time it all averages out and being a dividend growth investor I'm looking to take advantage of time in order to maximize my compounding returns.

As shown below, dividends have produced approximately 40 % of the stock market's total return over time.

Their dividend will go up and down over time because of the nature of their business, still they are the bluest of the blue - chip in alt investment industry.

This is meant to give you an idea of whether dividend growth rates are increasing or decreasing over time.

Today, with dividends reinvested, the value of each share has increased several times over despite the dot - com meltdown, the war on terror, higher national debt, and a declining dollar.

I'm sure dividend stocks will provide over 100 % returns if you give them a long enough amount of time.

The first will be organic growth of my existing portfolio by companies naturally increasing their dividends over time.

Dividend payments also give investors the opportunity to reinvest into more shares of stock, thus boosting future dividend payments and compounding gains ovDividend payments also give investors the opportunity to reinvest into more shares of stock, thus boosting future dividend payments and compounding gains ovdividend payments and compounding gains over time.

They can even pay out a dividend if they haven't done a profit by paying out some money out of their reserves but this will hurt the company hard and it can't be done over a long time - period.

While you can find plenty of stocks with higher yields, General Dynamics» double - digit dividend growth rate implies that over time, investors could collect a much higher yield on cost.

7 Dividend growth is the annualized percentage rate of growth that a particular stock's dividend undergoes over a period Dividend growth is the annualized percentage rate of growth that a particular stock's dividend undergoes over a period dividend undergoes over a period of time.

Investors can simply hold on to their shares, collect the dividend checks, and see the value of their holdings increase over time.

As of this writing, the portfolio is down 2.11 % including dividends, compared to a positive return of 11.63 % (excluding dividends) for SPY over the same period and 10.5 % for Vanguard Small Cap Value ETF (VBR) over the same time period.

Colgate - Palmolive won't be a high - growth stock for investors, but the dividend yield of 2.3 % is rock solid and will grow steadily over time.

You will receive dividends on the stock you buy with the dividends received, and over time your fund value will grow way above the average of an investor who does not do likewise.

As the name implies, the dividend appreciation index fund seeks to track a benchmark against stocks that have a history of increasing dividends over time.

That's more than three - times the earnings growth rate at dividend - paying companies of 4.6 % over the same period.

By investing in dividend growth companies, you'll be building passive streams of income that grow over time.

A company has control over how much it pays in dividends, but the masses of the market are the ones that determine the stock price at any given time, so the company growth and the dividends they pay are the primary points of focus for dividend growth investors.

The days of big capital infusions are over... there is only so many times I can steal from the home down payment fund Waiting for the dividend snowball to get bigger is it for now.

While never guaranteed, dividends provide a very reliable and predictable source of income and these monthly updates show real world examples of how that passive income stream not only rolls in but also grows over time.

As Dover is part of the few dividend kings who has underperformed the stock market over the past 10 years, it may be a good time to select this company.

The Index measures the performance of a selected group of equity securities issued by companies that have provided relatively high dividend yields on a consistent basis over time.

Identifying and investing in these companies for the long run is one of the most actionable ways that Do Nothing investing can build up your dividend income over time.

To sum up, the consistency of the Dividend Aristocrats means that these stocks are likely to generate more income over time even if you contribute no additional funds to your investment portfolio — which is Do Nothing investing at its finest.

There have been periods of time when exposure factors can, and have underperformed the market, such as dividend growth stocks over the last four years.

If you are prepared to make a significant capital investment aimed at paying dividends over time, then more of a traditional business loan or substantial line of credit may be the best path.

Recall that a common stock is a claim on the excess profits of a corporation, which are ultimately paid out as dividends over time.

If paid, dividends could help supplement your income, and the prices of many dividend - paying stocks have generally increased over time.

Quite simply, I think Canadian banks are profit machines that have a proven tendency to kick back a nice percentage of those profits to investors as dividends that grow over time.

Higher - quality dividend - paying stocks are understood within the industry to mean those issued by large, stable companies that generally invest in profitable projects, manage their expenses effectively, and grow their cash flow — some of the hallmarks of companies that are able to sustain and grow dividends over time.

Pan American Silver has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20 %).